Clinical and biological clusters of sepsis patients using hierarchical clustering.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
08
11
2020
accepted:
24
05
2021
entrez:
4
8
2021
pubmed:
5
8
2021
medline:
25
11
2021
Statut:
epublish
Résumé
Heterogeneity in sepsis expression is multidimensional, including highly disparate data such as the underlying disorders, infection source, causative micro-organismsand organ failures. The aim of the study is to identify clusters of patients based on clinical and biological characteristic available at patients' admission. All patients included in a national prospective multicenter ICU cohort OUTCOMEREA and admitted for sepsis or septic shock (Sepsis 3.0 definition) were retrospectively analyzed. A hierarchical clustering was performed in a training set of patients to build clusters based on a comprehensive set of clinical and biological characteristics available at ICU admission. Clusters were described, and the 28-day, 90-day, and one-year mortality were compared with log-rank rates. Risks of mortality were also compared after adjustment on SOFA score and year of ICU admission. Of the 6,046 patients with sepsis in the cohort, 4,050 (67%) were randomly allocated to the training set. Six distinct clusters were identified: young patients without any comorbidities, admitted in ICU for community-acquired pneumonia (n = 1,603 (40%)); young patients without any comorbidities, admitted in ICU for meningitis or encephalitis (n = 149 (4%)); elderly patients with COPD, admitted in ICU for bronchial infection with few organ failures (n = 243 (6%)); elderly patients, with several comorbidities and organ failures (n = 1,094 (27%)); patients admitted after surgery, with a nosocomial infection (n = 623 (15%)); young patients with immunosuppressive conditions (e.g., AIDS, chronic steroid therapy or hematological malignancy) (n = 338 (8%)). Clusters differed significantly in early or late mortality (p < .001), even after adjustment on severity of organ dysfunctions (SOFA) and year of ICU admission. Clinical and biological features commonly available at ICU admission of patients with sepsis or septic shock enabled to set up six clusters of patients, with very distinct outcomes. Considering these clusters may improve the care management and the homogeneity of patients in future studies.
Sections du résumé
BACKGROUND
Heterogeneity in sepsis expression is multidimensional, including highly disparate data such as the underlying disorders, infection source, causative micro-organismsand organ failures. The aim of the study is to identify clusters of patients based on clinical and biological characteristic available at patients' admission.
METHODS
All patients included in a national prospective multicenter ICU cohort OUTCOMEREA and admitted for sepsis or septic shock (Sepsis 3.0 definition) were retrospectively analyzed. A hierarchical clustering was performed in a training set of patients to build clusters based on a comprehensive set of clinical and biological characteristics available at ICU admission. Clusters were described, and the 28-day, 90-day, and one-year mortality were compared with log-rank rates. Risks of mortality were also compared after adjustment on SOFA score and year of ICU admission.
RESULTS
Of the 6,046 patients with sepsis in the cohort, 4,050 (67%) were randomly allocated to the training set. Six distinct clusters were identified: young patients without any comorbidities, admitted in ICU for community-acquired pneumonia (n = 1,603 (40%)); young patients without any comorbidities, admitted in ICU for meningitis or encephalitis (n = 149 (4%)); elderly patients with COPD, admitted in ICU for bronchial infection with few organ failures (n = 243 (6%)); elderly patients, with several comorbidities and organ failures (n = 1,094 (27%)); patients admitted after surgery, with a nosocomial infection (n = 623 (15%)); young patients with immunosuppressive conditions (e.g., AIDS, chronic steroid therapy or hematological malignancy) (n = 338 (8%)). Clusters differed significantly in early or late mortality (p < .001), even after adjustment on severity of organ dysfunctions (SOFA) and year of ICU admission.
CONCLUSIONS
Clinical and biological features commonly available at ICU admission of patients with sepsis or septic shock enabled to set up six clusters of patients, with very distinct outcomes. Considering these clusters may improve the care management and the homogeneity of patients in future studies.
Identifiants
pubmed: 34347776
doi: 10.1371/journal.pone.0252793
pii: PONE-D-20-35126
pmc: PMC8336799
doi:
Types de publication
Clinical Trial
Journal Article
Multicenter Study
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0252793Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Am J Respir Crit Care Med. 2014 May 15;189(10):1204-13
pubmed: 24635548
J Thorac Oncol. 2015 May;10(5):754-761
pubmed: 25898956
Intensive Care Med. 2015 May;41(5):814-22
pubmed: 25851384
JAMA. 1999 Aug 11;282(6):561-8
pubmed: 10450718
JAMA. 2019 Oct 8;322(14):1416-1417
pubmed: 31593266
Crit Care Med. 2006 Feb;34(2):344-53
pubmed: 16424713
N Engl J Med. 2013 Aug 29;369(9):840-51
pubmed: 23984731
Lancet Respir Med. 2014 Aug;2(8):611-20
pubmed: 24853585
Acad Emerg Med. 2016 Mar;23(3):269-78
pubmed: 26679719
Intensive Care Med. 2006 Nov;32(11):1706-12
pubmed: 16957907
Crit Care. 2012 Oct 04;16(5):R183
pubmed: 23036193
Intensive Care Med. 2017 Sep;43(9):1294-1305
pubmed: 28500455
Crit Care Med. 2017 Apr;45(4):e457
pubmed: 28291106
Am J Respir Crit Care Med. 2015 Nov 1;192(9):1045-51
pubmed: 26177009
Lancet Respir Med. 2015 Jan;3(1):53-60
pubmed: 25533491
PLoS One. 2016 Jun 17;11(6):e0157318
pubmed: 27314230
PLoS One. 2012;7(12):e51048
pubmed: 23236428
Genes Immun. 2004 Dec;5(8):631-40
pubmed: 15526005
JAMA. 2007 Sep 12;298(10):1209-12
pubmed: 17848656
Crit Care. 2018 Dec 18;22(1):347
pubmed: 30563548
Am J Respir Crit Care Med. 2015 Jun 1;191(11):1226-31
pubmed: 26029837
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
Am J Respir Crit Care Med. 2010 Feb 15;181(4):315-23
pubmed: 19892860
JAMA. 2019 May 28;321(20):2003-2017
pubmed: 31104070
Crit Care Med. 2018 Jun;46(6):915-925
pubmed: 29537985
Intensive Care Med. 2019 Jul;45(7):1025-1028
pubmed: 31062051
JAMA. 2019 Oct 8;322(14):1416
pubmed: 31593265
JAMA. 2016 Feb 23;315(8):775-87
pubmed: 26903336
Lancet Respir Med. 2016 Apr;4(4):259-71
pubmed: 26917434
Crit Care. 2005;9(6):626-8
pubmed: 16356249
Nat Methods. 2015 Nov;12(11):1033-8
pubmed: 26389570
Ann Rheum Dis. 2013 Jun;72(6):1003-10
pubmed: 22962314